English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/137497
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Efficient stereoselective synthesis of 2-acetamido-1,2- dideoxyallonojirimycin (DAJNAc) and sp2-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme

AuthorsFuente, Alex de la; Rísquez-Cuadro, Rocio; Verdaguer, Xavier; García-Fernández, José Manuel; Nanba, Eji; Higaki, Katsumi; Ortiz-Mellet, Carmen; Riera, Antoni
KeywordsHexosaminidase inhibitors
Stereoselective synthesis
Pharmacological chaperones
Tay-Sachs disease
Issue Date2016
CitationEuropean Journal of Medicinal Chemistry, 121: 926-938 (2016)
AbstractDue to their capacity to inhibit hexosaminidases, 2-acetamido-1,2-dideoxy-iminosugars have been widely studied as potential therapeutic agents for various diseases. An efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), the most potent inhibitor of human placenta b-Nacetylglucosaminidase (b-hexosaminidase) among the epimeric series, is here described. This novel procedure can be easily scaled up, providing enough material for structural modifications and further biological tests. Thus, two series of sp2-iminosugar conjugates derived from DAJNAc have been prepared, namely monocyclic DAJNAc-thioureas and bicyclic 2-iminothiazolidines, and their glycosidase inhibitory activity evaluated. The data evidence the utmost importance of developing diversity-oriented synthetic strategies allowing optimization of electrostatic and hydrophobic interactions to achieve high inhibitory potencies and selectivities among isoenzymes. Notably, strong differences in the inhibition potency of the compounds towards b-hexosaminidase from human placenta (mature) or cultured fibroblasts (precursor form) were encountered. The ensemble of data suggests that the ratio between them, and not the inhibition potency towards the placenta enzyme, is a good indication of the chaperoning potential of TaySachs disease-associated mutant hexosaminidase
Publisher version (URL)http://dx.doi.org/10.1016/j.ejmech.2015.10.038
Appears in Collections:(IIQ) Artículos
Files in This Item:
File Description SizeFormat 
García et al..pdf1,22 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.